Table1 Diagnosis in relation to demographic characteristics
Diagnosis | Pre-SARS-COV-2 group | During-SARS-COV-2 group | P value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Patients n (%) | Mean age | Gender | Patients | Mean age | Gender | ||||||
Male n (%) | Female n (%) | P value | Male n (%) | Female n(5) | P value | ||||||
Group1 | 413 (25.9%) | 31.4 ± 14.8 | 206 (49.9%) | 207 (50.1%) | 0.642 | 858 (35.1%) | 38.4 ± 17.9 | 423 (49.3%) | 435 (50.7%) | 0.339 | 0.000 |
Group2 | 314 (18.2%) | 30.9 ± 12.2 | 121 (38.5%) | 193 (61.5%) | 0.000 | 529 (21.7%) | 32.8 ± 14.7 | 156 (39.2%) | 242 (60.8%) | 0.000 | 0.005 |
Group3 | 24 (1.4%) | 31.8 ± 13.9 | 10 (41.7%) | 14 (58.3%) | 0.364 | 56 (2.3%) | 38.1 ± 26.0 | 33 (58.9%) | 23 (41.1%) | 0.008 | 0.043 |
Group4 | 161 (9.6%) | 35.5 ± 15.1 | 80 (49.7%) | 81 (50.3%) | 0.752 | 227 (9.3%) | 40.7 ± 19.4 | 122 (53.7%) | 105 (46.3%) | 0.322 | 0.715 |
Group5 | 695 (38.0%) | 15.2 ± 15.9 | 405 (58.3%) | 290 (41.7%) | 0.000 | 492 (20.1%) | 19.8 ± 17.9 | 286 (58.1%) | 206 (41.9%) | 0.000 | 0.000 |
Group6 | 58 (3.2%) | 23.5 ± 12.1 | 31 (53.4%) | 27 (46.6%) | 0.729 | 23 (0.9%) | 32.2 ± 17.6 | 10 (43.5%) | 13 (56.5%) | 0.492 | 0.000 |
Group7 | 51 (3.7%) | 26.5 ± 12.3 | 20 (39.2%) | 31 (60.8%) | 0.091 | 257 (10.5%) | 33.5 ± 21.0 | 127 (49.4%) | 130 (50.6%) | 0.685 |  |